1. Home
  2. YELP vs NEO Comparison

YELP vs NEO Comparison

Compare YELP & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yelp Inc.

YELP

Yelp Inc.

HOLD

Current Price

$26.02

Market Cap

1.2B

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$16.55

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YELP
NEO
Founded
2004
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Precision Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
2011
2008

Fundamental Metrics

Financial Performance
Metric
YELP
NEO
Price
$26.02
$16.55
Analyst Decision
Hold
Strong Buy
Analyst Count
6
8
Target Price
$29.17
$13.38
AVG Volume (30 Days)
947.3K
3.0M
Earning Date
05-07-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
19.15
N/A
EPS
0.30
N/A
Revenue
$1,464,955,000.00
N/A
Revenue This Year
$2.19
$10.63
Revenue Next Year
$2.34
$9.73
P/E Ratio
$83.47
N/A
Revenue Growth
3.75
N/A
52 Week Low
$19.60
$5.65
52 Week High
$34.49
$16.45

Technical Indicators

Market Signals
Indicator
YELP
NEO
Relative Strength Index (RSI) 45.69 59.79
Support Level $23.87 $13.43
Resistance Level $27.67 N/A
Average True Range (ATR) 1.16 0.81
MACD -0.17 0.04
Stochastic Oscillator 26.07 73.82

Price Performance

Historical Comparison
YELP
NEO

About YELP Yelp Inc.

Yelp Inc operates in the online content market based in the United States. It provides a web-based platform and mobile application to bridge the gap between businesses and consumers. The platform assists consumers through product reviews, tips, photos and videos thereby enabling them in making appropriate buying decisions and posting their feedbacks. Its products and services includes Advertising Products and Business Page Products. In addition, it also lets the buyers directly transact with businesses directly through its platform. Yelp generates revenue mainly from the sale of advertising on its website and mobile app to businesses. The company generates majority of the revenue from United States, and also has its presence in other countries.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: